Whether long-term use of ezetimibe is needed after stenting is mainly determined by whether the blood lipid control is up to the standard or not. If the blood lipid is still not up to the standard after taking statins, ezetimibe is needed to be added.
Ezetimibe is a lipid-lowering drug that lowers blood cholesterol levels by inhibiting the absorption of cholesterol in the small intestine, and is mostly used in the treatment of hypercholesterolemia.
Stent surgery is usually used for severe coronary atherosclerosis, high blood lipid is one of the main predisposing factors of the disease, postoperative patients should generally be long-term oral statin drugs, such as lipid control is still unable to achieve the target value, can be added to ezetimibe to lower lipids, if the use of statin can be used to make the blood lipid lowering the target range, then there is no need to take ezetimibe for a long period of time.
Note that ezetimibe is contraindicated in patients with hypersensitivity to the drug, and is contraindicated in patients with active liver disease when used in combination with HMG-CoA reductase inhibitors. Some patients may experience abdominal pain, diarrhea, fatigue, gastrointestinal gas and bloating, headache, fatigue and other adverse reactions, if the discomfort is more serious, should consult a doctor in time.
Patients after stent implantation should follow the doctor’s instructions to use the drug, and should not blindly use or discontinue the use of ezetimibe, in order to avoid affecting the condition.